STJ Pengajuan SEC - St. Jude Medical, Inc.- Laporan Tahunan, Pernyataan Kuasa, Prospektus

Mga Batayang Estadistika

CIK

203077

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to St. Jude Medical, Inc.

SEC Filings (Chronological Order)

Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.

March 7, 2017	425	ABBOTT LABORATORIES 425 (Prospectus) Filed by Abbott Laboratories Pursuant to Rule 425 under the Securities Act of 1933 Subject Company: St.
February 21, 2017	425	ABBOTT LABORATORIES 425 (Prospectus) Filed by Abbott Laboratories Pursuant to Rule 425 under the Securities Act of 1933 Subject Company: St.
February 14, 2017	SC 13G/A	STJ / St. Jude Medical, Inc. / MASSACHUSETTS FINANCIAL SERVICES CO /MA/ Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2 (AMENDMENT NO. 7)* St. Jude Medical, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 790849103 (CUSIP Number) 12/31/2016 (Date of Event Which Requires Filing of this State
February 10, 2017	SC 13G/A	STJ / St. Jude Medical, Inc. / VANGUARD GROUP INC Passive Investment stjudemedicalinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 2 )* Name of issuer: St Jude Medical Inc Title of Class of Securities: Common Stock CUSIP Number: 790849103 Date of Event Which Requires Filing of this Statement: December 31, 2016 Check the appropriate box
January 17, 2017	15-12B	St. Jude Medical 15-12B UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 1-12441 ST. JUDE MEDICAL, LLC (Exact name of registrant as specified in its
January 10, 2017	S-8 POS	St. Jude Medical S-8 POS S-8 POS 1 a16-2369532s8pos.htm S-8 POS As filed with the Securities and Exchange Commission on January 4, 2017 Registration No. 333-212872 Registration No. 333-207341 Registration No. 333-183159 Registration No. 333-183158 Registration No. 333-176200 Registration No. 333-150839 Registration No. 333-149440 Registration No. 333-143090 Registration No. 333-136398 Registration No. 333-130180 Registrat
January 10, 2017	S-8 POS	St. Jude Medical S-8 POS As filed with the Securities and Exchange Commission on January 4, 2017 Registration No.
January 10, 2017	S-8 POS	St. Jude Medical S-8 POS S-8 POS 1 a16-2369531s8pos.htm S-8 POS As filed with the Securities and Exchange Commission on January 4, 2017 Registration No. 333-212872 Registration No. 333-207341 Registration No. 333-183159 Registration No. 333-183158 Registration No. 333-176200 Registration No. 333-150839 Registration No. 333-149440 Registration No. 333-143090 Registration No. 333-136398 Registration No. 333-130180 Registrat
January 10, 2017	S-8 POS	St. Jude Medical S-8 POS S-8 POS 1 a16-2369533s8pos.htm S-8 POS As filed with the Securities and Exchange Commission on January 4, 2017 Registration No. 333-212872 Registration No. 333-207341 Registration No. 333-183159 Registration No. 333-183158 Registration No. 333-176200 Registration No. 333-150839 Registration No. 333-149440 Registration No. 333-143090 Registration No. 333-136398 Registration No. 333-130180 Registrat
January 10, 2017	S-8 POS	St. Jude Medical S-8 POS S-8 POS 1 a16-2369534s8pos.htm S-8 POS As filed with the Securities and Exchange Commission on January 4, 2017 Registration No. 333-212872 Registration No. 333-207341 Registration No. 333-183159 Registration No. 333-183158 Registration No. 333-176200 Registration No. 333-150839 Registration No. 333-149440 Registration No. 333-143090 Registration No. 333-136398 Registration No. 333-130180 Registrat
January 5, 2017	EX-4.1	Sixth Supplemental Indenture, dated as of January 4, 2017, among St. Jude Medical, Inc., St. Jude Medical, LLC and U.S. Bank National Association, as trustee, filed as Exhibit 4.1 to the St. Jude Medical, LLC Current Report on Form 8-K dated January 4, 2017. EX-4.1 4 a16-238861ex4d1.htm EX-4.1 EXHIBIT 4.1 SIXTH SUPPLEMENTAL INDENTURE This Sixth Supplemental Indenture, dated as of January 4, 2017 (this “Supplemental Indenture”), among St. Jude Medical, Inc., a Minnesota corporation (the “Original Issuer”) and wholly owned subsidiary of Abbott Laboratories, an Illinois corporation (“Abbott”), and St. Jude Medical, LLC (formerly known as Vault Merger Sub
January 5, 2017	EX-3.1	CERTIFICATE OF FORMATION VAULT MERGER SUB, LLC EXHIBIT 3.1 CERTIFICATE OF FORMATION OF VAULT MERGER SUB, LLC This CERTIFICATE of FORMATION of Vault Merger Sub, LLC, dated as of April 26, 2016 is being duly executed and filed by Sebastian L. Fain, as an authorized person of Vault Merger Sub, LLC, to form a limited liability company under the Delaware Limited Liability Company Act (6 Del.C. ? 18-101, et seq.). FIRST. The name of the limited liab
January 5, 2017	8-K	Changes in Control of Registrant, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Material Modification to Rights of Security Holders, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 4, 2017 St. Jude Medical, LLC (Exact Name of Registrant as Specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-12441 (Commission File Number) 3
January 5, 2017	EX-3.2	AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT ST. JUDE MEDICAL, LLC (f/k/a Vault Merger Sub, LLC) January 4, 2017 EXHIBIT 3.2 AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT OF ST. JUDE MEDICAL, LLC (f/k/a Vault Merger Sub, LLC) January 4, 2017 This AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT (this ?Agreement?) of St. Jude Medical, LLC, f/k/a Vault Merger Sub, LLC (the ?Company?) is entered into by the sole member, Abbott Laboratories, an Illinois corporation (the ?Member?), effective as
January 4, 2017	S-8 POS	St. Jude Medical S-8 POS S-8 POS 1 a16-2369517s8pos.htm S-8 POS As filed with the Securities and Exchange Commission on January 4, 2017 Registration No. 333-212872 Registration No. 333-207341 Registration No. 333-183159 Registration No. 333-183158 Registration No. 333-176200 Registration No. 333-150839 Registration No. 333-149440 Registration No. 333-143090 Registration No. 333-136398 Registration No. 333-130180 Registrat
January 4, 2017	S-8 POS	St. Jude Medical S-8 POS S-8 POS 1 a16-2369511s8pos.htm S-8 POS As filed with the Securities and Exchange Commission on January 4, 2017 Registration No. 333-212872 Registration No. 333-207341 Registration No. 333-183159 Registration No. 333-183158 Registration No. 333-176200 Registration No. 333-150839 Registration No. 333-149440 Registration No. 333-143090 Registration No. 333-136398 Registration No. 333-130180 Registrat
January 4, 2017	S-8 POS	St. Jude Medical S-8 POS As filed with the Securities and Exchange Commission on January 4, 2017 Registration No.
January 4, 2017	S-8 POS	St. Jude Medical S-8 POS As filed with the Securities and Exchange Commission on January 4, 2017 Registration No.
January 4, 2017	S-8 POS	St. Jude Medical S-8 POS As filed with the Securities and Exchange Commission on January 4, 2017 Registration No.
January 4, 2017	S-8 POS	St. Jude Medical S-8 POS As filed with the Securities and Exchange Commission on January 4, 2017 Registration No.
January 4, 2017	S-8 POS	St. Jude Medical S-8 POS As filed with the Securities and Exchange Commission on January 4, 2017 Registration No.
January 4, 2017	S-8 POS	St. Jude Medical S-8 POS As filed with the Securities and Exchange Commission on January 4, 2017 Registration No.
January 4, 2017	S-8 POS	St. Jude Medical S-8 POS As filed with the Securities and Exchange Commission on January 4, 2017 Registration No.
January 4, 2017	S-8 POS	St. Jude Medical S-8 POS As filed with the Securities and Exchange Commission on January 4, 2017 Registration No.
January 4, 2017	S-8 POS	St. Jude Medical S-8 POS As filed with the Securities and Exchange Commission on January 4, 2017 Registration No.
January 4, 2017	S-8 POS	St. Jude Medical S-8 POS As filed with the Securities and Exchange Commission on January 4, 2017 Registration No.
January 4, 2017	S-8 POS	St. Jude Medical S-8 POS As filed with the Securities and Exchange Commission on January 4, 2017 Registration No.
January 4, 2017	S-8 POS	St. Jude Medical S-8 POS As filed with the Securities and Exchange Commission on January 4, 2017 Registration No.
January 4, 2017	S-8 POS	St. Jude Medical S-8 POS As filed with the Securities and Exchange Commission on January 4, 2017 Registration No.
January 4, 2017	POS AM	St. Jude Medical S-3 As filed with the Securities and Exchange Commission on January 4, 2017 Registration No.
January 4, 2017	S-8 POS	St. Jude Medical S-8 POS As filed with the Securities and Exchange Commission on January 4, 2017 Registration No.
January 4, 2017	S-8 POS	St. Jude Medical S-8 POS S-8 POS 1 a16-2369518s8pos.htm S-8 POS As filed with the Securities and Exchange Commission on January 4, 2017 Registration No. 333-212872 Registration No. 333-207341 Registration No. 333-183159 Registration No. 333-183158 Registration No. 333-176200 Registration No. 333-150839 Registration No. 333-149440 Registration No. 333-143090 Registration No. 333-136398 Registration No. 333-130180 Registrat
January 4, 2017	POS AM	St. Jude Medical POS AM POS AM 1 a16-236971posam.htm POS AM As filed with the Securities and Exchange Commission on January 4, 2017 Registration No. 033-23194 Registration No. 033-10407 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO Form S-3 Registration Statement No. 033-23194 Form S-3 Registration Statement No. 033-10407 UNDER THE SECURITIES ACT OF 1933 St. Jud
January 4, 2017	S-8 POS	St. Jude Medical S-8 POS As filed with the Securities and Exchange Commission on January 4, 2017 Registration No.
January 4, 2017	S-8 POS	St. Jude Medical S-8 POS As filed with the Securities and Exchange Commission on January 4, 2017 Registration No.
January 4, 2017	S-8 POS	St. Jude Medical S-8 POS As filed with the Securities and Exchange Commission on January 4, 2017 Registration No.
January 4, 2017	S-8 POS	St. Jude Medical S-8 POS As filed with the Securities and Exchange Commission on January 4, 2017 Registration No.
January 4, 2017	S-8 POS	St. Jude Medical S-8 POS As filed with the Securities and Exchange Commission on January 4, 2017 Registration No.
January 4, 2017	S-8 POS	St. Jude Medical S-8 POS As filed with the Securities and Exchange Commission on January 4, 2017 Registration No.
January 4, 2017	S-8 POS	St. Jude Medical S-8 POS As filed with the Securities and Exchange Commission on January 4, 2017 Registration No.
January 4, 2017	S-8 POS	St. Jude Medical S-8 POS As filed with the Securities and Exchange Commission on January 4, 2017 Registration No.
January 4, 2017	S-8 POS	St. Jude Medical S-8 POS As filed with the Securities and Exchange Commission on January 4, 2017 Registration No.
January 4, 2017	EX-99.25	EX-99.25 EX-99.25 2 ruleprovisionnotice.htm NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES The New York Stock Exchange hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on January 17, 2017, pursuant to the provisions of Rule 12d2-2 (a). [ X ] 17 CFR 240.12d
January 4, 2017	S-8 POS	St. Jude Medical S-8 POS As filed with the Securities and Exchange Commission on January 4, 2017 Registration No.
January 4, 2017	S-8 POS	St. Jude Medical S-8 POS As filed with the Securities and Exchange Commission on January 4, 2017 Registration No.
January 4, 2017	S-8 POS	St. Jude Medical S-8 POS As filed with the Securities and Exchange Commission on January 4, 2017 Registration No.
January 4, 2017	S-8 POS	St. Jude Medical S-8 POS S-8 POS 1 a16-236954s8pos.htm S-8 POS As filed with the Securities and Exchange Commission on January 4, 2017 Registration No. 333-212872 Registration No. 333-207341 Registration No. 333-183159 Registration No. 333-183158 Registration No. 333-176200 Registration No. 333-150839 Registration No. 333-149440 Registration No. 333-143090 Registration No. 333-136398 Registration No. 333-130180 Registrati
December 30, 2016	425	ABBOTT LABORATORIES 425 (Prospectus) Filed by Abbott Laboratories Pursuant to Rule 425 under the Securities Act of 1933 Subject Company: St.
December 9, 2016	425	St. Jude Medical 425 (Prospectus) FILED BY ST. JUDE MEDICAL, INC. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14A-12 OF THE SECURITIES EXCHANGED ACT OF 1934 SUBJECT COMPANY: ST. JUDE MEDICAL, INC. COMMISSION FILE NO. 1-12441 St. Jude Medical, Inc. Global Headquarters One St. Jude Medical Drive St. Paul, MN 55117-9913 USA Tel 651 756 2000 sjm.com News Release CONTACTS: J.C. Weigelt Candac
November 7, 2016	EX-12	ST. JUDE MEDICAL, INC. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (amounts in millions of dollars) EXHIBIT 12 ST. JUDE MEDICAL, INC. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (amounts in millions of dollars) Nine Months Ended FISCAL YEAR October 1, 2016 2015 2014 2013 2012 2011 EARNINGS Earnings before income taxes and noncontrolling interest $ 651 $ 928 $ 1,068 $ 784 $ 1,005 $ 1,019 Plus fixed charges: Interest expense (1) 119 103 85 81 73 70 Rent interest factor (2) 11 15 17 12 15 15
November 7, 2016	10-Q	St. Jude Medical 10-Q (Quarterly Report) Document Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
October 27, 2016	EX-3.2	ST. JUDE MEDICAL, INC. ARTICLE I Exhibit 3.2 BYLAWS OF ST. JUDE MEDICAL, INC. ARTICLE I Shareholders Section 1. The shareholders of this corporation shall hold an annual meeting in each calendar year at such time and place, within or without the state of Minnesota, as may be designated by the Board of Directors, for the purpose of electing directors, and for the transaction only of such other business as is properly brought befor
October 27, 2016	EX-99.1	St. Jude Medical, Inc. Exhibit 99.1 St. Jude Medical, Inc. Global Headquarters One St. Jude Medical Drive St. Paul, MN 55117-9913 USA Tel 651 756 2000 sjm.com News Release MEDIA CONTACT: INVESTOR CONTACT: Candace Steele Flippin J.C. Weigelt [email protected] [email protected] Tel 651 756 3029 Tel 651 756 4347 St. Jude Medical Shareholders Approve Merger with Abbott ST. PAUL, Minn. ? October 26, 2016 ? St. Jude Medical, I
October 27, 2016	EX-10.1	ST. JUDE MEDICAL, INC. 2016 STOCK INCENTIVE PLAN Exhibit 10.1 ST. JUDE MEDICAL, INC. 2016 STOCK INCENTIVE PLAN TABLE OF CONTENTS Page SECTION 1. PURPOSE 1 SECTION 2. DEFINITIONS 1 SECTION 3. ADMINISTRATION 4 (a) Power and Authority of the Committee 4 (b) Delegation 5 (c) Power and Authority of the Board of Directors 5 SECTION 4. SHARES AVAILABLE FOR AWARDS 5 (a) Shares Available 5 (b) Counting Shares 6 (c) Adjustments 7 (d) Award Limitations Und
October 27, 2016	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: October 26, 2016 (Date of earliest event reported) ST. JUDE MEDICAL, INC. (Exact name of registrant as specified in its charter) Commission File Number: 1-12441 Minnesota 41-1276891 (State or other jurisdiction of inc
October 27, 2016	425	St. Jude Medical 8-K (Prospectus) 425 1 a16-2051618k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: October 26, 2016 (Date of earliest event reported) ST. JUDE MEDICAL, INC. (Exact name of registrant as specified in its charter) Commission File Number: 1-12441 Minnesota 41-1276891 (State o
October 27, 2016	EX-10.1	†St. Jude Medical, Inc. 2016 Stock Incentive Plan, filed as Exhibit 10.1 to the St. Jude Medical, Inc. Current Report on Form 8-K dated October 27, 2016.** EX-10.1 3 a16-205161ex10d1.htm EX-10.1 Exhibit 10.1 ST. JUDE MEDICAL, INC. 2016 STOCK INCENTIVE PLAN TABLE OF CONTENTS Page SECTION 1. PURPOSE 1 SECTION 2. DEFINITIONS 1 SECTION 3. ADMINISTRATION 4 (a) Power and Authority of the Committee 4 (b) Delegation 5 (c) Power and Authority of the Board of Directors 5 SECTION 4. SHARES AVAILABLE FOR AWARDS 5 (a) Shares Available 5 (b) Counting Shares 6 (c)
October 27, 2016	EX-3.2	ST. JUDE MEDICAL, INC. ARTICLE I Exhibit 3.2 BYLAWS OF ST. JUDE MEDICAL, INC. ARTICLE I Shareholders Section 1. The shareholders of this corporation shall hold an annual meeting in each calendar year at such time and place, within or without the state of Minnesota, as may be designated by the Board of Directors, for the purpose of electing directors, and for the transaction only of such other business as is properly brought befor
October 27, 2016	EX-99.1	St. Jude Medical, Inc. EX-99.1 4 a16-205161ex99d1.htm EX-99.1 Exhibit 99.1 St. Jude Medical, Inc. Global Headquarters One St. Jude Medical Drive St. Paul, MN 55117-9913 USA Tel 651 756 2000 sjm.com News Release MEDIA CONTACT: INVESTOR CONTACT: Candace Steele Flippin J.C. Weigelt [email protected] [email protected] Tel 651 756 3029 Tel 651 756 4347 St. Jude Medical Shareholders Approve Merger with Abbott ST. PAUL, Minn. —
October 19, 2016	425	ABBOTT LABORATORIES 425 (Prospectus) Filed by Abbott Laboratories Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: St.
October 19, 2016	EX-99.1	3Q16 Sales EX-99.1 2 a16-201261ex99d1.htm EX-99.1 Exhibit 99.1 St. Jude Medical, Inc. Global Headquarters One St. Jude Medical Drive St. Paul, MN 55117-9913 USA Tel 651 756 2000 sjm.com News Release MEDIA CONTACT: INVESTOR CONTACT: Candace Steele Flippin J.C. Weigelt [email protected] [email protected] Tel 651 756 3029 Tel 651 756 4347 St. Jude Medical Reports Third Quarter 2016 Results ST. PAUL, Minn. — Octo
October 19, 2016	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 a16-2012618k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 19, 2016 ST. JUDE MEDICAL, INC. (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 1-124
October 18, 2016	EX-99.1	2 Exhibit 99.1 News Release St. Jude Medical and Abbott to Sell Portion of Vascular Closure and Electrophysiology Businesses to Terumo Corporation ? The agreement is an important step toward completion of Abbott?s acquisition of St. Jude Medical ? Abbott?s acquisition of St. Jude Medical is expected to close by year-end ABBOTT PARK, Ill. and ST. PAUL, Minn., Oct. 18, 2016 ? Abbott and St. Jude Medic
October 18, 2016	EX-99.1	2 Exhibit 99.1 News Release St. Jude Medical and Abbott to Sell Portion of Vascular Closure and Electrophysiology Businesses to Terumo Corporation ? The agreement is an important step toward completion of Abbott?s acquisition of St. Jude Medical ? Abbott?s acquisition of St. Jude Medical is expected to close by year-end ABBOTT PARK, Ill. and ST. PAUL, Minn., Oct. 18, 2016 ? Abbott and St. Jude Medic
October 18, 2016	425	St. Jude Medical 8-K (Prospectus) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: October 18, 2016 (Date of earliest event reported) ST.
October 18, 2016	425	ABBOTT LABORATORIES 425 (Prospectus) Filed by Abbott Laboratories Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: St.
October 18, 2016	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: October 18, 2016 (Date of earliest event reported) ST.
September 26, 2016	DEFM14A	St. Jude Medical DEFM14A Use these links to rapidly review the document TABLE OF CONTENTS TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
September 8, 2016	425	ABBOTT LABORATORIES 425 (Prospectus) Filed by Abbott Laboratories Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: St.
August 3, 2016	EX-12	ST. JUDE MEDICAL, INC. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (amounts in millions of dollars) EX-12 4 a20160702ex12q2.htm COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES EXHIBIT 12 ST. JUDE MEDICAL, INC. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (amounts in millions of dollars) Six Months Ended FISCAL YEAR July 2, 2016 2015 2014 2013 2012 2011 EARNINGS Earnings before income taxes and noncontrolling interest $ 406 $ 928 $ 1,068 $ 784 $ 1,005 $ 1,019 Plus fixed charges: Interest e
August 3, 2016	S-8	St. Jude Medical S-8 As filed with the Securities and Exchange Commission on August 3, 2016 Registration No.
August 3, 2016	EX-10.1	AMENDMENT TO SEVERANCE AGREEMENT EXHIBIT 10.1 AMENDMENT TO SEVERANCE AGREEMENT This Amendment (the “Amendment”) is made as of the 31st day of May, 2016, between St. Jude Medical, Inc., a Minnesota corporation, with its principal offices at One St. Jude Medical Drive, St. Paul, Minnesota 55117 (the “Company”) and (“Executive”), and amends that certain Severance Agreement, dated, between Executive and the Company (the “Change in Co
August 3, 2016	EX-24.1	POWER OF ATTORNEY Exhibit 24.1 POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Michael T. Rousseau, Donald J. Zurbay and Jason A. Zellers, and each of them, the undersigned?s true and lawful attorneys-in-fact and agents, each acting alone, with the powers of substitution and revocation, for the undersigned and in the undersigned?s
August 3, 2016	EX-10.2	SECOND AMENDMENT TO SEVERANCE AGREEMENT EXHIBIT 10.2 SECOND AMENDMENT TO SEVERANCE AGREEMENT This Amendment (the “Amendment”) is made as of the 31st day of May, 2016, between St. Jude Medical, Inc., a Minnesota corporation, with its principal offices at One St. Jude Medical Drive, St. Paul, Minnesota 55117 (the “Company”) and (“Executive”), and amends that certain Severance Agreement, dated, between Executive and the Company, as amended
August 3, 2016	10-Q	St. Jude Medical 10-Q (Quarterly Report) Document Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
July 20, 2016	EX-99.1	2Q16 Sales Exhibit 99.1 St. Jude Medical, Inc. Global Headquarters One St. Jude Medical Drive St. Paul, MN 55117-9913 USA Tel 651 756 2000 sjm.com News Release MEDIA CONTACT: INVESTOR CONTACT: Candace Steele Flippin J.C. Weigelt [email protected] [email protected] Tel 651 756 3029 Tel 651 756 4347 St. Jude Medical Reports Second Quarter 2016 Results ST. PAUL, Minn. ? July 20, 2016 ? St. Jude Medical, Inc. (NY
July 20, 2016	425	ABBOTT LABORATORIES 425 (Prospectus) Filed by Abbott Laboratories Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: St.
July 20, 2016	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 20, 2016 ST. JUDE MEDICAL, INC. (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 1-12441 (Commission File Number) 41
July 12, 2016	8-K	Other Events 8-K 1 a16-1472518k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: July 11, 2016 (Date of earliest event reported) ST. JUDE MEDICAL, INC. (Exact name of registrant as specified in its charter) Commission File Number: 1-12441 Minnesota 41-1276891 (State or oth
July 12, 2016	425	St. Jude Medical 8-K (Prospectus) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: July 11, 2016 (Date of earliest event reported) ST.
July 12, 2016	425	ABBOTT LABORATORIES 8-K (Prospectus) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 11, 2016 Date of Report (Date of earliest event reported) ABBOTT LABORATORIES (Exact name of registrant as specified in its charter) Illinois 1-2189 36-0698440 (State or other Jurisdiction (Commission File Number) (IRS Employer of Incorporation) Identification No.
June 7, 2016	EX-99.1	PART II EX-99.1 3 a8-kexhibit99101022016.htm EX-99.1 EXHIBIT 99.1 PART II Item 6. SELECTED FINANCIAL DATA Five-Year Summary Financial Data (in millions, except per share amounts) 2015 2014 2013 2012 2011 Summary of Operations for the Fiscal Year: Net sales $ 5,541 $ 5,622 $ 5,501 $ 5,503 $ 5,612 Net earnings attributable to St. Jude Medical, Inc. $ 880 $ 1,002 $ 723 $ 752 $ 826 Diluted net earnings per sh
June 7, 2016	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report: June 7, 2016 (Date of earliest event reported) ST. JUDE MEDICAL, IN UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report: June 7, 2016 (Date of earliest event reported) ST. JUDE MEDICAL, INC. (Exact name of registrant as specified in its charter) Commission File Number: 1-12441 Minnesota 41-1276891 (State or other jurisdiction of (IRS Em
May 31, 2016	EX-1.01	St. Jude Medical, Inc. Conflict Minerals Report for the Year Ended December 31, 2015 Exhibit 1.01 St. Jude Medical, Inc. Conflict Minerals Report for the Year Ended December 31, 2015 Background This Conflict Minerals Report of St. Jude Medical, Inc. (referred to herein as ?St. Jude Medical,? ?we,? ?us,? or ?our?) for the reporting period of January 1, 2015 through December 31, 2015 has been prepared pursuant to Rule 13p-1 and Form SD (the ?Conflict Minerals Rule?) promulgated unde
May 31, 2016	SD	St. Jude Medical SD SD 1 a16-122471sd.htm SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report ST. JUDE MEDICAL, INC. (Exact name of registrant as specified in its charter) Minnesota 1-12441 41-1276891 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No.) One St. Jude Medical Drive St. Paul,
May 26, 2016	425	St. Jude Medical 425 (Prospectus) FILED BY ST. JUDE MEDICAL, INC. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14A-12 OF THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: ST. JUDE MEDICAL, INC. COMMISSION FILE NO. 1-12441 The following was made available to the employees of St. Jude Medical, Inc. on May 26, 2016: Overview: Treatment of Outstanding St. Jude Medical Equity Compensation A
May 13, 2016	425	St. Jude Medical 425 (Prospectus) FILED BY ST. JUDE MEDICAL, INC. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14A-12 OF THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: ST. JUDE MEDICAL, INC. COMMISSION FILE NO. 1-12441 The following was made available to the employees of St. Jude Medical, Inc. on May 12, 2016: ACQUISITION FREQUENTLY ASKED QUESTIONS GENERAL 1. What is happening? (Las
May 6, 2016	425	ABBOTT LABORATORIES 425 (Prospectus) 425 1 a16-97146425.htm 425 So they've had two active deals, obviously, St. Jude being the biggest, and this is a really great opportunity to talk with Tom and Brian more at a high strategic level. And so I'd really like to keep it on that since we have Tom here and talk more a strategic direction. * * MAY 05, 2016 / 12:00PM GMT, ABT - Abbott Laboratories at Deutsche Bank Health Care Conference
May 4, 2016	EX-12	ST. JUDE MEDICAL, INC. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (amounts in millions of dollars) EXHIBIT 12 ST. JUDE MEDICAL, INC. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (amounts in millions of dollars) Three Months Ended FISCAL YEAR April 2, 2016 2015 2014 2013 2012 2011 EARNINGS Earnings before income taxes and noncontrolling interest $ 136 $ 928 $ 1,068 $ 784 $ 1,005 $ 1,019 Plus fixed charges: Interest expense (1) 40 103 85 81 73 70 Rent interest factor (2) 4 15 17 12 15 15 TOT
May 4, 2016	EX-10.1	ST. JUDE MEDICAL, INC. 2007 STOCK INCENTIVE PLAN AS AMENDED AND RESTATED (2014) RESTRICTED STOCK AWARD CERTIFICATE EXHIBIT 10.1 ST. JUDE MEDICAL, INC. 2007 STOCK INCENTIVE PLAN AS AMENDED AND RESTATED (2014) RESTRICTED STOCK AWARD CERTIFICATE This certifies that is granted a Restricted Stock Award for shares of Common Stock, $.10 par value, of St. Jude Medical, Inc., a Minnesota corporation. Social Security/ID Number: Grant Date: , 20 Expiration Date of Restricted Period: Vesting Schedule: This Restricted Stoc
May 4, 2016	10-Q	St. Jude Medical 10-Q (Quarterly Report) 10-Q 1 stj-2016040210qq1.htm 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED APRIL 2, 2016 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . C
April 28, 2016	425	ABBOTT LABORATORIES 425 (Prospectus) 425 1 a16-97142425.htm 425 Filed by Abbott Laboratories (Commission File No. 1-2189) Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: St. Jude Medical, Inc. (Commission File No. 1-12441) Fact Sheet Abbott’s Acquisition of St. Jude Medical at a Glance TODAY’S ANNOUNCEMENT Abbott (NYSE: ABT) has agr
April 28, 2016	425	St. Jude Medical 425 (Prospectus) FILED BY ST. JUDE MEDICAL, INC. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14A-12 OF THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: ST. JUDE MEDICAL, INC. COMMISSION FILE NO. 1-12441 To: From: [Distributor] [SJM Leader] Date: April 28, 2016 Subject: Abbott to acquire St. Jude Medical Dear [Distributor], Today we announced that St. Jude Medical has
April 28, 2016	425	St. Jude Medical 425 (Prospectus) FILED BY ST. JUDE MEDICAL, INC. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14A-12 OF THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: ST. JUDE MEDICAL, INC. COMMISSION FILE NO. 1-12441 The following was made available to the employees of St. Jude Medical, Inc. on April 28, 2016: For internal use only. Do not distribute ABBOTT AGREEMENT: KEY MESSAGES
April 28, 2016	EX-99.1	Increase / (Decrease) Exhibit 99.1 News Release Abbott to Acquire St. Jude Medical COMBINATION WILL CREATE A PREMIER MEDICAL DEVICE LEADER AND STRENGTHEN ABBOTT?S LONG-TERM GROWTH POTENTIAL ? Acquisition will enhance Abbott?s global scale and capabilities and will further diversify its portfolio of best-in-class products and revenue sources ? Combined portfolio will include top positions in high-growth markets and an i
April 28, 2016	EX-99.2	Creating A Premier Medical Device Leader April 28, 2016 Exhibit 99.2 Creating A Premier Medical Device Leader April 28, 2016 Information Related to This Communication Important Additional Information In connection with the proposed transaction, Abbott intends to file a registration statement on Form S-4 with the SEC which will include a document that serves as a prospectus of Abbott and a proxy statement of St. Jude Medical (the "proxy statement/ prosp
April 28, 2016	EX-99.2	Creating A Premier Medical Device Leader April 28, 2016 Exhibit 99.2 Creating A Premier Medical Device Leader April 28, 2016 Information Related to This Communication Important Additional Information In connection with the proposed transaction, Abbott intends to file a registration statement on Form S-4 with the SEC which will include a document that serves as a prospectus of Abbott and a proxy statement of St. Jude Medical (the "proxy statement/ prosp
April 28, 2016	EX-99.1	Increase / (Decrease) EX-99.1 3 a16-97141ex99d1.htm EX-99.1 Exhibit 99.1 News Release Abbott to Acquire St. Jude Medical COMBINATION WILL CREATE A PREMIER MEDICAL DEVICE LEADER AND STRENGTHEN ABBOTT’S LONG-TERM GROWTH POTENTIAL · Acquisition will enhance Abbott’s global scale and capabilities and will further diversify its portfolio of best-in-class products and revenue sources · Combined portfolio will include top pos
April 28, 2016	425	ABBOTT LABORATORIES 425 (Prospectus) Filed by Abbott Laboratories (Commission File No. 1-2189) Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: St. Jude Medical, Inc. (Commission File No. 1-12441) THOMSON REUTERS STREETEVENTS \| www.streetevents.com \| Contact Us ©2016 Thomson Reuters. All rights reserved. Republication or redistributi
April 28, 2016	425	St. Jude Medical 8-K (Prospectus) 425 1 a16-970918k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: April 27, 2016 (Date of earliest event reported) ST. JUDE MEDICAL, INC. (Exact name of registrant as specified in its charter) Commission File Number: 1-12441 Minnesota 41-1276891 (State or oth
April 28, 2016	425	St. Jude Medical 425 (Prospectus) FILED BY ST. JUDE MEDICAL, INC. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14A-12 OF THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: ST. JUDE MEDICAL, INC. COMMISSION FILE NO. 1-12441 To: [Customer] From: Mike Rousseau, President & CEO Date: April 28, 2016 Subject: Abbott to Acquire St. Jude Medical Dear [Customer], Today we announced that St. Jude
April 28, 2016	425	ABBOTT LABORATORIES 425 (Prospectus) Filed by Abbott Laboratories (Commission File No. 1-2189) Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Subject Company: St. Jude Medical, Inc. (Commission File No. 1-12441) ABBOTT Creating TO ACQUIRE ST. JUDE MEDICAL A Premier Medical Device Leader St. Paul, Minnesota Global leader in cardiac and neuromodulati
April 28, 2016	EX-2.1	AGREEMENT AND PLAN OF MERGER dated as of April 27, 2016 by and among ABBOTT LABORATORIES, ST. JUDE MEDICAL, INC., VAULT MERGER SUB, INC. VAULT MERGER SUB, LLC Exhibit 2.1 EXECUTION VERSION AGREEMENT AND PLAN OF MERGER dated as of April 27, 2016 by and among ABBOTT LABORATORIES, ST. JUDE MEDICAL, INC., VAULT MERGER SUB, INC. and VAULT MERGER SUB, LLC TABLE OF CONTENTS Article 1 Definitions Section 1.01 Definitions 6 Section 1.02 Other Definitional and Interpretative Provisions 22 Article 2 THE MERGERS; EFFECT ON THE CAPITAL STOCK; EXCHANGE OF CERTIFICATE
April 28, 2016	EX-2.1	AGREEMENT AND PLAN OF MERGER dated as of April 27, 2016 by and among ABBOTT LABORATORIES, ST. JUDE MEDICAL, INC., VAULT MERGER SUB, INC. VAULT MERGER SUB, LLC Exhibit 2.1 EXECUTION VERSION AGREEMENT AND PLAN OF MERGER dated as of April 27, 2016 by and among ABBOTT LABORATORIES, ST. JUDE MEDICAL, INC., VAULT MERGER SUB, INC. and VAULT MERGER SUB, LLC TABLE OF CONTENTS Article 1 Definitions Section 1.01 Definitions 6 Section 1.02 Other Definitional and Interpretative Provisions 22 Article 2 THE MERGERS; EFFECT ON THE CAPITAL STOCK; EXCHANGE OF CERTIFICATE
April 28, 2016	425	St. Jude Medical 425 (Prospectus) FILED BY ST. JUDE MEDICAL, INC. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14A-12 OF THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: ST. JUDE MEDICAL, INC. COMMISSION FILE NO. 1-12441 To: [Supplier/Vendor] From: [SJM Leader] Date: April 28, 2016 Subject: Abbott to acquire St. Jude Medical Dear [Supplier/Vendor], Today we announced that St. Jude Med
April 28, 2016	EX-2.1	AGREEMENT AND PLAN OF MERGER dated as of April 27, 2016 by and among ABBOTT LABORATORIES, ST. JUDE MEDICAL, INC., VAULT MERGER SUB, INC. VAULT MERGER SUB, LLC Exhibit 2.1 EXECUTION VERSION AGREEMENT AND PLAN OF MERGER dated as of April 27, 2016 by and among ABBOTT LABORATORIES, ST. JUDE MEDICAL, INC., VAULT MERGER SUB, INC. and VAULT MERGER SUB, LLC TABLE OF CONTENTS Article 1 Definitions Section 1.01 Definitions 6 Section 1.02 Other Definitional and Interpretative Provisions 22 Article 2 THE MERGERS; EFFECT ON THE CAPITAL STOCK; EXCHANGE OF CERTIFICATE
April 28, 2016	EX-3.2	AMENDMENTS TO ST. JUDE MEDICAL, INC. EX-3.2 3 a16-97091ex3d2.htm EX-3.2 Exhibit 3.2 AMENDMENTS TO BYLAWS OF ST. JUDE MEDICAL, INC. Pursuant to resolutions unanimously adopted by the Board of Directors (the “Board”) of St. Jude Medical, Inc., a Minnesota corporation (the “Corporation”) on April 27, 2016, the Bylaws of the Corporation (the “Bylaws”) were amended as follows: 1. The first sentence of Article I, Section 1 of the Bylaws wa
April 28, 2016	425	St. Jude Medical 425 (Prospectus) 425 1 a16-98148425.htm 425 FILED BY ST. JUDE MEDICAL, INC. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14A-12 OF THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: ST. JUDE MEDICAL, INC. COMMISSION FILE NO. 1-12441 The following was made available to employees of St. Jude Medical, Inc. on April 28, 2016: Abbott Resource Center Page 1 of 2 Search by key
April 28, 2016	EX-99.1	Increase / (Decrease) Exhibit 99.1 News Release Abbott to Acquire St. Jude Medical COMBINATION WILL CREATE A PREMIER MEDICAL DEVICE LEADER AND STRENGTHEN ABBOTT?S LONG-TERM GROWTH POTENTIAL ? Acquisition will enhance Abbott?s global scale and capabilities and will further diversify its portfolio of best-in-class products and revenue sources ? Combined portfolio will include top positions in high-growth markets and an i
April 28, 2016	425	St. Jude Medical 425 (Prospectus) FILED BY ST. JUDE MEDICAL, INC. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14A-12 OF THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: ST. JUDE MEDICAL, INC. COMMISSION FILE NO. 1-12441 The following was made available to the employees of St. Jude Medical, Inc. on April 28, 2016: From: Mike Rousseau To: All employees Today I am pleased to announce th
April 28, 2016	EX-3.2	AMENDMENTS TO ST. JUDE MEDICAL, INC. EX-3.2 3 a16-97091ex3d2.htm EX-3.2 Exhibit 3.2 AMENDMENTS TO BYLAWS OF ST. JUDE MEDICAL, INC. Pursuant to resolutions unanimously adopted by the Board of Directors (the “Board”) of St. Jude Medical, Inc., a Minnesota corporation (the “Corporation”) on April 27, 2016, the Bylaws of the Corporation (the “Bylaws”) were amended as follows: 1. The first sentence of Article I, Section 1 of the Bylaws wa
April 28, 2016	EX-99.2	Creating A Premier Medical Device Leader April 28, 2016 EX-99.2 4 a16-97141ex99d2.htm EX-99.2 Exhibit 99.2 Creating A Premier Medical Device Leader April 28, 2016 Information Related to This Communication Important Additional Information In connection with the proposed transaction, Abbott intends to file a registration statement on Form S-4 with the SEC which will include a document that serves as a prospectus of Abbott and a proxy statement of St. Jud
April 28, 2016	425	ABBOTT LABORATORIES 8-K (Prospectus) 425 1 a16-971418k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 27, 2016 Date of Report (Date of earliest event reported) ABBOTT LABORATORIES (Exact name of registrant as specified in its charter) Illinois 1-2189 36-0698440 (State or other jurisdiction of incorporati
April 28, 2016	425	St. Jude Medical 425 (Prospectus) 425 1 a16-98141425.htm 425 FILED BY ST. JUDE MEDICAL, INC. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14A-12 OF THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: ST. JUDE MEDICAL, INC. COMMISSION FILE NO. 1-12441 To: [Trial Investigators] From: [Appropriate Leader within SJM] Date: [TBD] Subject: Abbott to acquire St. Jude Medical Because you are par
April 28, 2016	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events 8-K 1 a16-970918k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: April 27, 2016 (Date of earliest event reported) ST. JUDE MEDICAL, INC. (Exact name of registrant as specified in its charter) Commission File Number: 1-12441 Minnesota 41-1276891 (State or oth
April 28, 2016	425	St. Jude Medical 425 (Prospectus) 425 1 a16-98147425.htm 425 FILED BY ST. JUDE MEDICAL, INC. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14A-12 OF THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: ST. JUDE MEDICAL, INC. COMMISSION FILE NO. 1-12441 The following was made available to the employees of St. Jude Medical, Inc. on April 28, 2016: ACQUISITION FREQUENTLY ASKED QUESTIONS GENER
April 20, 2016	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 20, 2016 ST. JUDE MEDICAL, INC. (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 1-12441 (Commission File Number) 4
April 20, 2016	EX-99.1	1Q16 Sales Exhibit 99.1 St. Jude Medical, Inc. Global Headquarters One St. Jude Medical Drive St. Paul, MN 55117-9913 USA Tel 651 756 2000 sjm.com News Release MEDIA CONTACT: INVESTOR CONTACT: Candace Steele Flippin J.C. Weigelt [email protected] [email protected] Tel 651 756 3029 Tel 651 756 4347 St. Jude Medical Reports First Quarter 2016 Results ST. PAUL, Minn. ? April 20, 2016 ? St. Jude Medical, Inc. (NY
March 22, 2016	DEF 14A	St. Jude Medical DEF 14A Use these links to rapidly review the document TABLE OF CONTENTS APPENDIX A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
March 8, 2016	PRE 14A	St. Jude Medical PRE 14A PRE 14A 1 a2227612zpre14a.htm PRE 14A Use these links to rapidly review the document TABLE OF CONTENTS APPENDIX A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: ý Pre
February 23, 2016	EX-12	ST. JUDE MEDICAL, INC. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (amounts in millions of dollars) EXHIBIT 12 ST. JUDE MEDICAL, INC. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (amounts in millions of dollars) FISCAL YEAR 2015 2014 2013 2012 2011 EARNINGS Earnings before noncontrolling interest and income taxes $ 928 $ 1,068 $ 784 $ 1,005 $ 1,019 Plus fixed charges: Interest expense (1) 103 85 81 73 70 Rent interest factor (2) 15 17 12 15 15 TOTAL FIXED CHARGES 118 102 93 88 85 EARNINGS B
February 23, 2016	EX-24	POWER OF ATTORNEY EXHIBIT 24 POWER OF ATTORNEY KNOW ALL BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Michael T.
February 23, 2016	EX-21	ST. JUDE MEDICAL, INC. SUBSIDIARIES OF THE REGISTRANT as of January 2, 2016 EXHIBIT 21 ST. JUDE MEDICAL, INC. SUBSIDIARIES OF THE REGISTRANT as of January 2, 2016 St. Jude Medical, Inc. Wholly Owned Subsidiaries: • Pacesetter, Inc. - Sylmar, California; Scottsdale, Arizona; and Maven, South Carolina (Delaware corporation) (dba St. Jude Medical Cardiac Rhythm Management Division) • California Property Holdings III Trust • California Property Holdings III LLC • St. Jude Med
February 23, 2016	EX-10.27	AMENDMENT NO. 1 TO TERM LOAN AGREEMENT EXHIBIT 10.27 AMENDMENT NO. 1 TO TERM LOAN AGREEMENT This Amendment No. 1 to Term Loan Agreement (this “Amendment”) dated as of February 19, 2016 is made by and among ST. JUDE MEDICAL, INC., a Minnesota corporation (the “Borrower”), each lender party hereto (collectively, the “Lenders” and individually, a “Lender”), and BANK OF AMERICA, N.A., as Administrative Agent and a Lender (in such capacity,
February 23, 2016	10-K	St. Jude Medical 10-K (Annual Report) 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended January 2, 2016 Commission File Number: 1-12441 ST. JUDE MEDICAL, INC. (Exact name of registrant as specified in its charter) Minnesota 41-1276891 (State or other jurisdiction of (I.R.S. Employer Iden
February 23, 2016	EX-10.29	AMENDMENT NO. 1 TO AMENDED AND RESTATED MULTI-YEAR $1,500,000,000 CREDIT AGREEMENT EXHIBIT 10.29 AMENDMENT NO. 1 TO AMENDED AND RESTATED MULTI-YEAR $1,500,000,000 CREDIT AGREEMENT This Amendment No. 1 to Amended and Restated Multi-Year $1,500,000,000 Credit Agreement (this “Amendment”) dated as of February 19, 2016 is made by and among ST. JUDE MEDICAL, INC., a Minnesota corporation (the “Borrower”), each lender party hereto (collectively, the “Lenders” and individually, a “Lend
February 23, 2016	EX-10.4	St. Jude Medical, Inc. Management Savings Plan Effective January 1, 2016 EX-10.4 2 exhibit10401022016.htm ST. JUDE MEDICAL, INC. MANAGEMENT SAVINGS PLAN, AS AMENDED AND RESTATED (2016) EXHIBIT 10.4 St. Jude Medical, Inc. Management Savings Plan Effective January 1, 2016 St. Jude Medical, Inc. Management Savings Plan Article I Establishment and Purpose 1 Article II Definitions 1 Article III Eligibility and Participation 10 Article IV Deferrals 11 Article V Company Contr
February 12, 2016	SC 13G/A	STJ / St. Jude Medical, Inc. / MASSACHUSETTS FINANCIAL SERVICES CO /MA/ - ST. JUDE MEDICAL, INC. Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2 (AMENDMENT NO. 6)* St. Jude Medical, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 790849103 (CUSIP Number) 12/31/2015 (Date of Event Which Requires Filing of this State
February 10, 2016	SC 13G/A	STJ / St. Jude Medical, Inc. / VANGUARD GROUP INC Passive Investment stjudemedicalinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1 )* Name of issuer: St Jude Medical Inc Title of Class of Securities: Common Stock CUSIP Number: 790849103 Date of Event Which Requires Filing of this Statement: December 31, 2015 Check the appropriate box
January 27, 2016	EX-99.1	4Q15 Sales Exhibit 99.1 St. Jude Medical, Inc. Global Headquarters One St. Jude Medical Drive St. Paul, MN 55117-9913 USA Tel 651 756 2000 sjm.com News Release MEDIA CONTACT: INVESTOR CONTACT: Candace Steele Flippin J.C. Weigelt [email protected] [email protected] Tel 651 756 3029 Tel 651 756 4347 St. Jude Medical Reports Fourth Quarter and Full-Year 2015 Results ST. PAUL, Minn. ? Jan. 27, 2016 ? St. Jude Med
January 27, 2016	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 27, 2016 ST. JUDE MEDICAL, INC. (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 1-12441 (Commission File Number)
January 13, 2016	EX-99.1	Pacemakers Ventricular Assist Devices Atrial Fibrillation ($1.1B) Atrial Fibrillation ($1.1B) Structural Heart ($0.6B) Vascular ($0.7B) PCI Optimization Vascular Closure Other Vascular Cardiac Rhythm Mgmt. (CRM) Cardiovascular PRODUCT CATEGORY REALIG Exhibit 99.1 Pacemakers Ventricular Assist Devices Atrial Fibrillation ($1.1B) Atrial Fibrillation ($1.1B) Structural Heart ($0.6B) Vascular ($0.7B) PCI Optimization Vascular Closure Other Vascular Cardiac Rhythm Mgmt. (CRM) Cardiovascular PRODUCT CATEGORY REALIGNMENT Comparable PriorComparable New ICD Systems ($1.6B)Traditional CRM ($1.6B) ICDsICDs CRT-DPacemakers Pacemaker Systems ($0.9B)Heart F
January 13, 2016	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 13, 2016 ST. JUDE MEDICAL, INC. (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 1-12441 (Commission File Number)
January 13, 2016	EX-99.2	COMPARABLE SALES BY PRODUCT CATEGORY Exhibit 99.2 COMPARABLE SALES BY PRODUCT CATEGORY Worldwide Comparable Sales (in millions) (unaudited) Product Category 2013 Comparable Sales 2014 Comparable Sales Comparable % Change Comparable CC % Change Comparable $ Change Comparable CC $ Change Foreign Currency Impact Heart Failure $1,435 $1,469 2% 3% $34 $38 -$5 Atrial Fibrillation $975 $1,069 10% 11% $94 $111 -$17 Neuromodulation $426 $437
January 13, 2016	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 a16-180728k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 13, 2016 ST. JUDE MEDICAL, INC. (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 1-1244
January 13, 2016	EX-99.1	4Q15 Sales EX-99.1 2 a16-18072ex99d1.htm EX-99.1 Exhibit 99.1 St. Jude Medical, Inc. Global Headquarters One St. Jude Medical Drive St. Paul, MN 55117-9913 USA Tel 651 756 2000 sjm.com News Release MEDIA CONTACT: INVESTOR CONTACT: Candace Steele Flippin J.C. Weigelt [email protected] [email protected] Tel 651 756 3029 Tel 651 756 4347 St. Jude Medical Announces Preliminary Fourth Quarter 2015 Financial Result
December 18, 2015	8-K/A	Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets 8-K/A 1 a15-2521518ka.htm 8-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 8, 2015 ST. JUDE MEDICAL, INC. (Exact name of registrant as specified in its charter) Minnesota 1-12441 41-1276891 (State or other jurisdiction
December 18, 2015	EX-99.3	UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION EX-99.3 3 a15-252151ex99d3.htm EX-99.3 Exhibit 99.3 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION The following unaudited condensed combined pro forma financial information illustrates the estimated effect to the acquisition by St. Jude Medical, Inc. (“St. Jude”) of Thoratec Corporation (“Thoratec”) in a transaction to be accounted for as a business combination and the effects of ad
December 14, 2015	EX-10.2	ST. JUDE MEDICAL, INC. EXECUTIVE SEVERANCE PLAN Effective January 1, 2016 Exhibit 10.2 ST. JUDE MEDICAL, INC. EXECUTIVE SEVERANCE PLAN Effective January 1, 2016 ST. JUDE MEDICAL, INC. EXECUTIVE SEVERANCE PLAN TABLE OF CONTENTS SECTION 1 - INTRODUCTION 1 SECTION 2 - DEFINITIONS 1 SECTION 3 - ELIGIBILITY FOR SEVERANCE 2 SECTION 4 - AMOUNT OF SEVERANCE PAY AND OTHER BENEFITS 3 SECTION 5 - WHEN SEVERANCE PAY WILL BE PAID 3 SECTION 6 ? EXECUTIVE?S AGREEMENTS 3 SECTION 7 - MI
December 14, 2015	EX-10.1	FIRST AMENDMENT TO SEVERANCE AGREEMENT EX-10.1 2 a15-249661ex10d1.htm EX-10.1 Exhibit 10.1 FIRST AMENDMENT TO SEVERANCE AGREEMENT This Amendment is made as of the day of , 20, between St. Jude Medical, Inc., a Minnesota corporation, with its principal offices at One St. Jude Medical Drive, St. Paul, Minnesota 55117 (the “Company”) and (“Executive”), residing at and amends that certain Severance Agreement, dated , 20, between Executive
December 14, 2015	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits 8-K 1 a15-2496618k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 8, 2015 ST. JUDE MEDICAL, INC. (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 1-124
December 11, 2015	8-K/A	St. Jude Medical 8-K/A (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: September 9, 2015 (Date of earliest event reported) ST.
November 10, 2015	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED OCTOBER 3, 2015 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . Commission File Number: 1-12441 S
November 10, 2015	EX-12	ST. JUDE MEDICAL, INC. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (amounts in millions of dollars) EXHIBIT 12 ST. JUDE MEDICAL, INC. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (amounts in millions of dollars) Nine Months Ended FISCAL YEAR October 3, 2015 2014 2013 2012 2011 2010 EARNINGS Earnings before income taxes and noncontrolling interest $ 863 $ 1,068 $ 784 $ 1,005 $ 1,019 $ 1,209 Plus fixed charges: Interest expense (1) 63 85 81 73 70 67 Rent interest factor (2) 13 17 12 15 15 12
October 21, 2015	EX-99.1	3Q15 Sales Exhibit 99.1 St. Jude Medical, Inc. Global Headquarters One St. Jude Medical Drive St. Paul, MN 55117-9913 USA Tel 651 756 2000 sjm.com News Release MEDIA CONTACT: INVESTOR CONTACT: Kate Stoltenberg J.C. Weigelt [email protected] [email protected] Tel 651 756 3388 Tel 651 756 4347 St. Jude Medical Reports Third Quarter 2015 Results ST. PAUL, Minn. ? October 21, 2015 ? St. Jude Medical, Inc. (NYS
October 21, 2015	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 a15-2144118k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 21, 2015 ST. JUDE MEDICAL, INC. (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 1-124
October 8, 2015	EX-99.1	St. Jude Medical Completes Acquisition of Thoratec Exhibit 99.1 St. Jude Medical, Inc. Global Headquarters One St. Jude Medical Drive St. Paul, MN 55117-9913 USA Tel 651 756 2000 sjm.com News Release CONTACTS: J.C. Weigelt Candace Steele Flippin Investor Relations Media Relations Tel 651 756 4347 Tel 651 756 3029 [email protected] [email protected] St. Jude Medical Completes Acquisition of Thoratec ST. PAUL, Minn.? October 8, 2015 ? St. Jude Medica
October 8, 2015	S-8	St. Jude Medical S-8 As filed with the Securities and Exchange Commission on October 8, 2015 Registration No.
October 8, 2015	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: October 8, 2015 (Date of earliest event reported) ST.
October 8, 2015	EX-99.1	THORATEC CORPORATION AMENDED AND RESTATED 2006 INCENTIVE STOCK PLAN Approved by the Shareholders on May 25, 2006 Amended and Restated by the Board on May 25, 2006 and April 7, 2008 Approved by the Shareholders on May 20, 2008 Amended and Restated by Exhibit 99.1 THORATEC CORPORATION AMENDED AND RESTATED 2006 INCENTIVE STOCK PLAN Approved by the Shareholders on May 25, 2006 Amended and Restated by the Board on May 25, 2006 and April 7, 2008 Approved by the Shareholders on May 20, 2008 Amended and Restated by the Board on May 20, 2008 and March 2, 2010 Approved by the Shareholders on May 19, 2010 Amended and Restated by the Board on December 7,
October 2, 2015	EX-99.1	DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Atlanta District Office 60 Eighth Street N.E. Atlanta, GA 30309 Telephone: 404-253-1161 FAX: 404-253-1202 September 30, 2015 VIA UPS Daniel J. Starks President and Chief Executive O Exhibit 99.1 DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Atlanta District Office 60 Eighth Street N.E. Atlanta, GA 30309 Telephone: 404-253-1161 FAX: 404-253-1202 September 30, 2015 VIA UPS Daniel J. Starks President and Chief Executive Officer St. Jude Medical, Inc. One Street Jude Medical Drive St. Paul, MN 55117 WARNING LETTER (15-ATL-13) Dear Mr. Starks: During an insp
October 2, 2015	8-K	Financial Statements and Exhibits, Other Events 8-K 1 a15-2068118k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 1, 2015 ST. JUDE MEDICAL, INC. (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 1-1244
September 23, 2015	EX-4.1	Fifth Supplemental Indenture, dated as of September 23, 2015, between St. Jude Medical, LLC (successor to St. Jude Medical, Inc.) and U.S. Bank National Association, as trustee, relating to St. Jude Medical, LLC’s 2.000% Senior Notes due 2018, 2.800% Senior Notes due 2020 and 3.875% Senior Notes due 2025, filed as Exhibit 4.1 to the St. Jude Medical, Inc. Current Report on Form 8-K dated September 23, 2015. Exhibit 4.1 FIFTH SUPPLEMENTAL INDENTURE ST. JUDE MEDICAL, INC. AND U.S. BANK NATIONAL ASSOCIATION, AS TRUSTEE Fifth Supplemental Indenture Dated as of September 23, 2015 Supplementing the Indenture Dated as of July 28, 2009 FIFTH SUPPLEMENTAL INDENTURE, dated as of September 23, 2015 (this ?Fifth Supplemental Indenture?), between St. Jude Medical, Inc., a corporation duly organized and existing u
September 23, 2015	8-K	St. Jude Medical 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report: September 23, 2015 (Date of earliest event reported) ST.
September 16, 2015	EX-1.1	St. Jude Medical, Inc. $500,000,000 2.000% Senior Notes due 2018 $500,000,000 2.800% Senior Notes due 2020 $500,000,000 3.875% Senior Notes due 2025 UNDERWRITING AGREEMENT September 14, 2015 Merrill Lynch, Pierce, Fenner & Smith Mitsubishi UFJ Securi EX-1.1 2 a15-196871ex1d1.htm EX-1.1 Exhibit 1.1 EXECUTION VERSION St. Jude Medical, Inc. $500,000,000 2.000% Senior Notes due 2018 $500,000,000 2.800% Senior Notes due 2020 $500,000,000 3.875% Senior Notes due 2025 UNDERWRITING AGREEMENT September 14, 2015 Merrill Lynch, Pierce, Fenner & Smith Incorporated Mitsubishi UFJ Securities (USA), Inc. Wells Fargo Securities, LLC Underwriting Agreement Sep
September 16, 2015	8-K	Financial Statements and Exhibits, Other Events 8-K 1 a15-1968718k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report: September 14, 2015 (Date of earliest event reported) ST. JUDE MEDICAL, INC. (Exact name of registrant as specified in its charter) Minnesota 1-12441 41-1276891 (State or Other Jurisdiction (Co
September 16, 2015	424B2	CALCULATION OF REGISTRATION FEE Use these links to rapidly review the document TABLE OF CONTENTS TABLE OF CONTENTS Filed Pursuant to Rule 424(b)(2) Registration No.
September 14, 2015	FWP	ST. JUDE MEDICAL, INC. Term Sheet September 14, 2015 2.000% Notes due 2018 2.800% Notes due 2020 3.875% Notes due 2025 Free Writing Prospectus Filed Pursuant to Rule 433 Registration Statement No. 333-187405 ST. JUDE MEDICAL, INC. Term Sheet September 14, 2015 2.000% Notes due 2018 2.800% Notes due 2020 3.875% Notes due 2025 Issuer: St. Jude Medical, Inc. Expected Ratings (Moodys / S&P / Fitch)*: Baa2 (negative outlook) / A (negative watch) / A- (stable outlook) Format: SEC Registered Ranking: Senior Unsecured Tr
September 14, 2015	424B5	SUBJECT TO COMPLETION, DATED SEPTEMBER 14, 2015 Use these links to rapidly review the document TABLE OF CONTENTS TABLE OF CONTENTS Table of Contents Filed Pursuant to Rule 424(b)5 Registration Statement No.
September 9, 2015	8-K	St. Jude Medical 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: September 9, 2015 (Date of earliest event reported) ST.
September 9, 2015	EX-99.1	St. Jude Medical Announces Leadership Transition Plan Daniel J. Starks to Become Executive Chairman, Effective January 1, 2016 Michael T. Rousseau to Succeed Starks as President and Chief Executive Officer Exhibit 99.1 St. Jude Medical, Inc. Global Headquarters One St. Jude Medical Drive St. Paul, MN 55117-9913 USA Tel 651 756 2000 sjm.com News Release CONTACTS: J.C. Weigelt Investor Relations Tel 651 756 4347 [email protected] Candace Steele Flippin Media Relations Tel 651 756 3029 [email protected] St. Jude Medical Announces Leadership Transition Plan Daniel J. Starks to Become Executive Chairman,
August 24, 2015	EX-10.1	TERM LOAN AGREEMENT Dated as of August 21, 2015 ST. JUDE MEDICAL, INC., as the Borrower, BANK OF AMERICA, N.A., as Administrative Agent and Lender, WELLS FARGO BANK, NATIONAL ASSOCIATION, THE BANK OF TOKYO-MITSUBISHI UFJ, LTD., and U.S. BANK, NATIONA EX-10.1 2 a15-184191ex10d1.htm EX-10.1 Exhibit 10.1 Execution Version Published CUSIP Number: 85230DAQ7 TERM LOAN AGREEMENT Dated as of August 21, 2015 among ST. JUDE MEDICAL, INC., as the Borrower, BANK OF AMERICA, N.A., as Administrative Agent and Lender, WELLS FARGO BANK, NATIONAL ASSOCIATION, THE BANK OF TOKYO-MITSUBISHI UFJ, LTD., and U.S. BANK, NATIONAL ASSOCIATION, as Co-Syndication Agents
August 24, 2015	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: August 21, 2015 (Date of earliest event reported) ST.
August 24, 2015	EX-10.2	AMENDED AND RESTATED MULTI-YEAR CREDIT AGREEMENT Dated as of August 21, 2015 ST. JUDE MEDICAL, INC., as the Borrower, BANK OF AMERICA, N.A., as Administrative Agent, L/C Issuer and Lender, The Other Lenders Party Hereto, WELLS FARGO BANK, N.A., THE B Exhibit 10.2 EXECUTION VERSION Published CUSIP Number: 85230DAT1 AMENDED AND RESTATED MULTI-YEAR $1,500,000,000 CREDIT AGREEMENT Dated as of August 21, 2015 among ST. JUDE MEDICAL, INC., as the Borrower, BANK OF AMERICA, N.A., as Administrative Agent, L/C Issuer and Lender, and The Other Lenders Party Hereto, WELLS FARGO BANK, N.A., THE BANK OF TOKYO-MITSUBISHI UFJ, LTD., and U.S. BANK, NATIONAL A
August 5, 2015	EX-10.1	TERM LOAN AGREEMENT Dated as of May 1, 2015 ST. JUDE MEDICAL, INC., (prior to the effectiveness of the Luxembourg Joinder, as the Borrower), ST. JUDE MEDICAL INTERNATIONAL HOLDING S.?.R.L., (upon and after the effectiveness of the Luxembourg Joinder, EXHIBIT 10.1 TERM LOAN AGREEMENT Dated as of May 1, 2015 between ST. JUDE MEDICAL, INC., (prior to the effectiveness of the Luxembourg Joinder, as the Borrower), ST. JUDE MEDICAL INTERNATIONAL HOLDING S.?.R.L., (upon and after the effectiveness of the Luxembourg Joinder, as the Borrower) and BANK OF AMERICA, N.A., as the Lender TABLE OF CONTENTS Section Page ARTICLE I. DEFINITIONS AND ACCOUNTING T
August 5, 2015	EX-12	ST. JUDE MEDICAL, INC. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (amounts in millions of dollars) EXHIBIT 12 ST. JUDE MEDICAL, INC. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (amounts in millions of dollars) Six Months Ended FISCAL YEAR July 4, 2015 2014 2013 2012 2011 2010 EARNINGS Earnings before income taxes and noncontrolling interest $ 602 $ 1,068 $ 784 $ 1,005 $ 1,019 $ 1,209 Plus fixed charges: Interest expense (1) 41 85 81 73 70 67 Rent interest factor (2) 9 17 12 15 15 12 TOTAL
August 5, 2015	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JULY 4, 2015 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . Commission File Number: 1-12441 ST.
August 5, 2015	EX-99.1	St. Jude Medical, Inc. Exhibit 99.1 St. Jude Medical, Inc. Global Headquarters One St. Jude Medical Drive St. Paul, MN 55117-9913 USA Tel 651 756 2000 sjm.com News Release CONTACTS: J.C. Weigelt Candace Steele Flippin Investor Relations Media Relations Tel 651 756 4347 Tel 651 756 3029 [email protected] [email protected] St. Jude Medical Appoints David Dvorak to its Board of Directors ST. PAUL, Minn. ? August 5, 2015 ? S
August 5, 2015	8-K	St. Jude Medical 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 4, 2015 ST. JUDE MEDICAL, INC. (Exact name of registrant as specified in its charter) Minnesota 1-12441 41-1276891 (State or other jurisdiction of incorporation) (Commission Fil
July 22, 2015	8-K	Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 8-K 1 a15-1600128k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: July 21, 2015 (Date of earliest event reported) ST. JUDE MEDICAL, INC. (Exact name of registrant as specified in its charter) Commission File Number: 1-12441 Minnesota 41-1276891 (State or oth
July 22, 2015	EX-10.1	VOTING AGREEMENT EX-10.1 3 a15-160012ex10d1.htm EX-10.1 Exhibit 10.1 EXECUTION VERSION VOTING AGREEMENT VOTING AGREEMENT, dated as of July 21, 2015 (this “Agreement”), among SJM International, Inc., a Delaware corporation (“Parent”), and the shareholders of Thoratec Corporation, a California corporation (the “Company”), listed on Schedule A hereto (each, a “Shareholder” and, collectively, the “Shareholders”). RECI
July 22, 2015	EX-99.1	2Q15 Sales Exhibit 99.1 St. Jude Medical, Inc. Global Headquarters One St. Jude Medical Drive St. Paul, MN 55117-9913 USA Tel 651 756 2000 sjm.com News Release MEDIA CONTACT: INVESTOR CONTACT: Kate Stoltenberg J.C. Weigelt [email protected] [email protected] Tel 651 756 3388 Tel 651 756 4347 St. Jude Medical Reports Second Quarter 2015 Results ST. PAUL, Minn. ? July 22, 2015 ? St. Jude Medical, Inc. (NYSE:
July 22, 2015	EX-10.2	MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED BANK OF AMERICA, N.A. One Bryant Park New York, New York 10036 Exhibit 10.2 EXECUTION VERSION MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED BANK OF AMERICA, N.A. One Bryant Park New York, New York 10036 CONFIDENTIAL July 21, 2015 St. Jude Medical, Inc. One St. Jude Medical Drive St. Paul, MN 55117 Attention: General Counsel Project Thunder 364-Day Bridge Facility Commitment Letter Ladies and Gentlemen: You (“you” or the “Borrower”) have advised Bank of A
July 22, 2015	EX-2.1	AGREEMENT AND PLAN OF MERGER SJM International, Inc., Spyder Merger Corporation, St. Jude Medical, Inc., Thoratec Corporation Dated as of July 21, 2015 EX-2.1 2 a15-160012ex2d1.htm EX-2.1 Exhibit 2.1 EXECUTION VERSION AGREEMENT AND PLAN OF MERGER among SJM International, Inc., Spyder Merger Corporation, St. Jude Medical, Inc., and Thoratec Corporation Dated as of July 21, 2015 TABLE OF CONTENTS Page ARTICLE 1 THE MERGER 2 1.1 The Merger 2 1.2 Closing and Effective Time of the Merger 3 ARTICLE 2 CONVERSION OF SECURITIES IN THE MERGER 3 2.1 Convers
July 22, 2015	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 a15-1600118k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 22, 2015 ST. JUDE MEDICAL, INC. (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 1-12441
July 22, 2015	EX-99.1	St. Jude Medical and Thoratec Announce Definitive Agreement Combination Accelerates Innovation-Based Growth Program and Expands Heart Failure Franchise St. Jude Medical Will Discuss Transaction on its Second Quarter 2015 Earnings Call Scheduled for 8 Exhibit 99.1 News Release ST. JUDE MEDICAL CONTACTS: THORATEC CONTACT: J.C. Weigelt Candace Steele Flippin Neil Meyer Investor Relations Public Relations Investor Relations Tel 651 756 4347 Tel 651 756 3029 Tel 925 738 0029 [email protected] [email protected] [email protected] St. Jude Medical and Thoratec Announce Definitive Agreement Combination Accelerates Innovation-Based Growth Program a
June 1, 2015	EX-1.01	St. Jude Medical, Inc. Conflict Minerals Report for the Year Ended December 31, 2014 Exhibit 1.01 St. Jude Medical, Inc. Conflict Minerals Report for the Year Ended December 31, 2014 Background This Conflict Minerals Report of St. Jude Medical, Inc. (referred to herein as ?St. Jude Medical,? ?we,? ?us,? or ?our?) for the reporting period of January 1, 2014 through December 31, 2014 has been prepared pursuant to Rule 13p-1 and Form SD (the ?Conflict Minerals Rule?) promulgated unde
June 1, 2015	SD	St. Jude Medical SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report ST. JUDE MEDICAL, INC. (Exact name of registrant as specified in its charter) Minnesota 1-12441 41-1276891 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No.) One St. Jude Medical Drive St. Paul, Minnesota 55117 (Address
May 8, 2015	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders 8-K 1 a15-1111818k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: May 7, 2015 (Date of earliest event reported) ST. JUDE MEDICAL, INC. (Exact name of registrant as specified in its charter) Commission File Number: 1-12441 Minnesota 41-1276891 (State or oth
May 8, 2015	EX-10.1	ST. JUDE MEDICAL, INC. AMENDED AND RESTATED MANAGEMENT INCENTIVE COMPENSATION PLAN (AS ADOPTED ON DECEMBER 8, 2014) Exhibit 10.1 ST. JUDE MEDICAL, INC. AMENDED AND RESTATED MANAGEMENT INCENTIVE COMPENSATION PLAN (AS ADOPTED ON DECEMBER 8, 2014) TABLE OF CONTENTS Section 1. Purpose 1 Section 2. Definitions 1 Section 3. Eligibility 2 Section 4. Administration 2 (a) Timing of Designations 2 (b) Adjustments 2 (c) Certifications 2 Section 5. Financial Performance Goals 2 Section 6. Payment of Incentive Compensation;
May 7, 2015	EX-12	ST. JUDE MEDICAL, INC. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (amounts in millions of dollars) EXHIBIT 12 ST. JUDE MEDICAL, INC. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (amounts in millions of dollars) Three Months Ended FISCAL YEAR April 4, 2015 2014 2013 2012 2011 2010 EARNINGS Earnings before income taxes and noncontrolling interest $ 308 $ 1,068 $ 784 $ 1,005 $ 1,019 $ 1,209 Plus fixed charges: Interest expense (1) 21 85 81 73 70 67 Rent interest factor (2) 4 17 12 15 15 12 TO
May 7, 2015	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q 10-Q 1 stj-2015040410qq1.htm 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED APRIL 4, 2015 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . C
April 22, 2015	EX-99.1	1Q15 Sales Exhibit 99.1 St. Jude Medical, Inc. Global Headquarters One St. Jude Medical Drive St. Paul, MN 55117-9913 USA Tel 651 756 2000 sjm.com News Release MEDIA CONTACT: INVESTOR CONTACT: Kate Stoltenberg J.C. Weigelt [email protected] [email protected] Tel 651 756 3388 Tel 651 756 4347 St. Jude Medical Reports First Quarter 2015 Results ST. PAUL, Minn. ? April 22, 2015 ? St. Jude Medical, Inc. (NYSE:
April 22, 2015	8-K	St. Jude Medical 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 22, 2015 ST. JUDE MEDICAL, INC. (Exact name of registrant as specified in its charter) Minnesota 1-12441 41-1276891 (State or other jurisdiction of incorporation) (Commission Fil
April 17, 2015	PX14A6G	April 17, 2015 April 17, 2015 Dear Fellow St. Jude Medical, Inc. Shareowner: Support Shareowner Proposal #6 Requesting Proxy Access The California Public Employees Retirement System (CalPERS) and the New York City Pension Funds urge shareowners to vote “FOR” proposal #6 – a non-binding proposal to give shareowners effective access to the director nomination process – at the St. Jude Medical, Inc. annual meeting
March 25, 2015	DEF 14A	St. Jude Medical DEF 14A Use these links to rapidly review the document TABLE OF CONTENTS APPENDIX A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
March 2, 2015	PRE 14A	STJ / St. Jude Medical, Inc. PRE 14A - - PRE 14A Use these links to rapidly review the document TABLE OF CONTENTS APPENDIX A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
February 26, 2015	EX-10.22	St. Jude Medical, Inc. 2007 Stock Incentive Plan, as amended and restated (2014), filed as Exhibit 10.22 to St. Jude Medical, Inc. Annual Report on Form 10-K for the year ended January 3, 2015 dated February 26, 2015.** EX-10.22 5 exhibit102201032015.htm ST. JUDE MEDICAL, INC. 2007 STOCK INCENTIVE PLAN AS AMENDED AND RESTATED (2014) EXHIBIT 10.22 ST. JUDE MEDICAL, INC. 2007 STOCK INCENTIVE PLAN AS AMENDED AND RESTATED (2014) TABLE OF CONTENTS Page Section 1. Purpose 1 Section 2. Definitions 1 Section 3. Administration 4 (a) Power and Authority of the Committee 4 (b) Delegation 4 (c) Power and Authority of the Boa
February 26, 2015	EX-12	ST. JUDE MEDICAL, INC. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (amounts in millions of dollars) EXHIBIT 12 ST. JUDE MEDICAL, INC. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (amounts in millions of dollars) FISCAL YEAR 2014 2013 2012 2011 2010 EARNINGS Earnings before noncontrolling interest and income taxes $ 1,068 $ 784 $ 1,005 $ 1,019 $ 1,208 Plus fixed charges: Interest expense (1) 85 81 73 70 67 Rent interest factor (2) 17 12 15 15 12 TOTAL FIXED CHARGES 102 93 88 85 79 EARNINGS B
February 26, 2015	EX-24	POWER OF ATTORNEY EXHIBIT 24 POWER OF ATTORNEY KNOW ALL BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Daniel J.
February 26, 2015	EX-10.13	ST. JUDE MEDICAL, INC. 2006 STOCK PLAN AS AMENDED AND RESTATED (2014) ST. JUDE MEDICAL, INC. 2006 STOCK PLAN AS AMENDED AND RESTATED (2014) EXHIBIT 10.13 ST. JUDE MEDICAL, INC. 2006 STOCK PLAN AS AMENDED AND RESTATED (2014) ST. JUDE MEDICAL, INC. 2006 STOCK PLAN AS AMENDED AND RESTATED (2014) SECTION 1. General Purpose of Plan; Definitions. The name of this plan is the St. Jude Medical, Inc. 2006 Stock Plan (the “Plan”). The purpose of the Plan is to enable the Company and its Subsidiaries to retain and attract executives and other ke
February 26, 2015	EX-10.9	FIFTH AMENDMENT TO THE ST. JUDE MEDICAL, INC. MANAGEMENT SAVINGS PLAN EXHIBIT 10.9 FIFTH AMENDMENT TO THE ST. JUDE MEDICAL, INC. MANAGEMENT SAVINGS PLAN THIS INSTRUMENT, amending the St. Jude Medical, Inc. Management Savings Plan as restated effective January 1, 2008 (the ?Plan?) is adopted by St. Jude Medical, Inc., a Minnesota corporation, (the ?Company?) and is effective as of January 1, 2015, except as otherwise noted below. RECITALS WHEREAS, the Company has her
February 26, 2015	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended January 3, 2015 Commission File Number: 1-12441 ST. JUD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended January 3, 2015 Commission File Number: 1-12441 ST. JUDE MEDICAL, INC. (Exact name of registrant as specified in its charter) Minnesota 41-1276891 (State or other jurisdiction of (I.R.S. Employer Identific
February 26, 2015	EX-21	ST. JUDE MEDICAL, INC. SUBSIDIARIES OF THE REGISTRANT as of January 3, 2015 EXHIBIT 21 ST. JUDE MEDICAL, INC. SUBSIDIARIES OF THE REGISTRANT as of January 3, 2015 St. Jude Medical, Inc. Wholly Owned Subsidiaries: ? Pacesetter, Inc. - Sylmar, California; Scottsdale, Arizona; and Maven, South Carolina (Delaware corporation) (dba St. Jude Medical Cardiac Rhythm Management Division) ? St. Jude Medical S.C., Inc. - Austin, Texas (Minnesota corporation) ? St. Jude Medical Europ
February 26, 2015	EX-10.11	ST. JUDE MEDICAL, INC. 2002 STOCK PLAN AS AMENDED AND RESTATED (2014) ST. JUDE MEDICAL, INC. 2002 STOCK PLAN AS AMENDED AND RESTATED (2014) EX-10.11 3 exhibit101101032015.htm ST. JUDE MEDICAL, INC. 2002 STOCK PLAN AS AMENDED AND RESTATED (2014) EXHIBIT 10.11 ST. JUDE MEDICAL, INC. 2002 STOCK PLAN AS AMENDED AND RESTATED (2014) ST. JUDE MEDICAL, INC. 2002 STOCK PLAN AS AMENDED AND RESTATED (2014) SECTION 1. General Purpose of Plan; Definitions. The name of this plan is the St. Jude Medical, Inc. 2002 Stock Plan (the “Plan”). The purpos
February 11, 2015	SC 13G/A	STJ / St. Jude Medical, Inc. / MASSACHUSETTS FINANCIAL SERVICES CO /MA/ - ST. JUDE MEDICAL, INC. Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2 (AMENDMENT NO. 5)* St. Jude Medical, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 790849103 (CUSIP Number) 12/31/2014 (Date of Event Which Requires Filing of this State
February 11, 2015	SC 13G	STJ / St. Jude Medical, Inc. / VANGUARD GROUP INC Passive Investment stjudemedicalinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 0 )* Name of issuer: St Jude Medical Inc Title of Class of Securities: Common Stock CUSIP Number: 790849103 Date of Event Which Requires Filing of this Statement: December 31, 2014 Check the appropriate box
January 28, 2015	EX-99.1	4Q14 Sales Exhibit 99.1 St. Jude Medical, Inc. Global Headquarters One St. Jude Medical Drive St. Paul, MN 55117-9913 USA Tel 651 756 2000 sjm.com News Release MEDIA CONTACT: INVESTOR CONTACT: Micki Sievwright J.C. Weigelt [email protected] [email protected] Tel 651 756 4615 Tel 651 756 4347 St. Jude Medical Reports Fourth Quarter and Full-Year 2014 Results ST. PAUL, Minn. – Jan. 28, 2015 – St. Jude Medical
January 28, 2015	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 28, 2015 ST. JUDE MEDICAL, INC. (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 1-12441 (Commission File Number)
January 14, 2015	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 14, 2015 ST. JUDE MEDICAL, INC. (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 1-12441 (Commission File Number)
January 14, 2015	EX-99.1	4Q14 Sales Exhibit 99.1 St. Jude Medical, Inc. Global Headquarters One St. Jude Medical Drive St. Paul, MN 55117-9913 USA Tel 651 756 2000 sjm.com News Release MEDIA CONTACT: INVESTOR CONTACT: Micki Sievwright J.C. Weigelt [email protected] [email protected] Tel 651 756 4615 Tel 651 756 4347 St. Jude Medical Announces Preliminary Fourth Quarter Financial Results and Authorization of a $500 Million Share Rep
December 19, 2014	CORRESP	STJ / St. Jude Medical, Inc. CORRESP - - CORRESP 1 filename1.htm St. Jude Medical, Inc. One St. Jude Medical Drive St. Paul, MN 55117 USA Main 651 756 2000 Fax 651 756 3301 December 19, 2014 Ms. Cecilia Blye Chief, Office of Global Security Risk United States Securities and Exchange Commission 100 F. Street, N.E. Washington, DC 20549 Subject: St. Jude Medical, Inc. Form 10-K for the Fiscal Year Ended December 28, 2013 Filed February 26,
November 4, 2014	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 27, 2014 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . Commission File Number: 1-1244
November 4, 2014	EX-10.2	THIRD AMENDMENT TO THE ST. JUDE MEDICAL, INC. MANAGEMENT SAVINGS PLAN EXHIBIT 10.2 THIRD AMENDMENT TO THE ST. JUDE MEDICAL, INC. MANAGEMENT SAVINGS PLAN THIS INSTRUMENT, amending the St. Jude Medical, Inc. Management Savings Plan as restated effective January 1, 2008 (the ?Plan?), is adopted by St. Jude Medical, Inc., a Minnesota corporation, (the ?Company?), and shall be effective as of August 1, 2014. RECITALS WHEREAS, the Company has heretofore established and ma
November 4, 2014	EX-10.1	TERM LOAN AGREEMENT Dated as of August 6, 2014 ST. JUDE MEDICAL, INC., as the Borrower, BANK OF AMERICA, N.A., as the Lender EXHIBIT 10.1 TERM LOAN AGREEMENT Dated as of August 6, 2014 between ST. JUDE MEDICAL, INC., as the Borrower, and BANK OF AMERICA, N.A., as the Lender 575266385 TABLE OF CONTENTS Section Page ARTICLE I. DEFINITIONS AND ACCOUNTING TERMS 1 1.01 Defined Terms 1 1.02 Other Interpretive Provisions 16 1.03 Accounting Terms 16 1.04 Rounding 17 1.05 References to Agreements and Laws 17 1.06 Times of Day; R
November 4, 2014	EX-10.3	FOURTH AMENDMENT OF THE ST. JUDE MEDICAL, INC. MANAGEMENT SAVINGS PLAN EXHIBIT 10.3 FOURTH AMENDMENT OF THE ST. JUDE MEDICAL, INC. MANAGEMENT SAVINGS PLAN THIS INSTRUMENT, amending the St. Jude Medical, Inc. Management Savings Plan (the ?Plan?) is adopted by St. Jude Medical, Inc., a Minnesota corporation, (the ?Employer?) and is effective as of January 1, 2015. RECITALS WHEREAS, the Employer has heretofore established and maintains (the ?Plan?) as a nonqualified def
November 4, 2014	EX-12	ST. JUDE MEDICAL, INC. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (amounts in millions of dollars) EXHIBIT 12 ST. JUDE MEDICAL, INC. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (amounts in millions of dollars) Nine Months Ended FISCAL YEAR September 27, 2014 2013 2012 2011 2010 2009 EARNINGS Earnings before income taxes and noncontrolling interest $ 810 $ 784 $ 1,005 $ 1,019 $ 1,209 $ 1,057 Plus fixed charges: Interest expense (1) 63 81 73 70 67 46 Rent interest factor (2) 9 12 15 15 12 1
October 15, 2014	EX-99.1	St. Jude Medical, Inc. Exhibit 99.1 St. Jude Medical, Inc. Global Headquarters One St. Jude Medical Drive St. Paul, MN 55117-9913 USA Tel 651 756 2000 sjm.com News Release MEDIA CONTACT: INVESTOR CONTACT: Micki Sievwright J.C. Weigelt [email protected] [email protected] Tel 651 756 4615 Tel 651 756 4347 St. Jude Medical Reports Third Quarter 2014 Results ST. PAUL, Minn. – October 15, 2014 – St. Jude Medical, Inc. (NYSE
October 15, 2014	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 15, 2014 ST. JUDE MEDICAL, INC. (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 1-12441 (Commission File Number)
July 30, 2014	EX-12	ST. JUDE MEDICAL, INC. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (amounts in millions of dollars) EXHIBIT 12 ST. JUDE MEDICAL, INC. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (amounts in millions of dollars) Six Months Ended FISCAL YEAR June 28, 2014 2013 2012 2011 2010 2009 EARNINGS Earnings before income taxes and noncontrolling interest $ 560 $ 784 $ 1,005 $ 1,019 $ 1,209 $ 1,057 Plus fixed charges: Interest expense (1) 42 81 73 70 67 46 Rent interest factor (2) 6 12 15 15 12 11 TOTA
July 30, 2014	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 28, 2014 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . Commission File Number: 1-12441 ST.
July 16, 2014	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 16, 2014 ST. JUDE MEDICAL, INC. (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 1-12441 (Commission File Number) 41
July 16, 2014	EX-99.1	2Q14 Sales Exhibit 99.1 St. Jude Medical, Inc. Global Headquarters One St. Jude Medical Drive St. Paul, MN 55117-9913 USA Tel 651 756 2000 sjm.com News Release MEDIA CONTACT: INVESTOR CONTACT: Micki Sievwright J.C. Weigelt [email protected] [email protected] Tel 651 756 4615 Tel 651 756 4347 St. Jude Medical Reports Second Quarter 2014 Results ST. PAUL, Minn. — July 16, 2014 — St. Jude Medical, Inc. (NYSE:
June 2, 2014	SD	- SD SD 1 a14-143521sd.htm SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report ST. JUDE MEDICAL, INC. (Exact name of registrant as specified in its charter) Minnesota 1-12441 41-1276891 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No.) One St. Jude Medical Drive St. Paul,
June 2, 2014	EX-1.02	St. Jude Medical, Inc. Conflict Minerals Report for the Year Ended December 31, 2013 Exhibit 1.02 St. Jude Medical, Inc. Conflict Minerals Report for the Year Ended December 31, 2013 Background On August 22, 2012, the U.S. Securities and Exchange Commission (SEC) issued the final conflict minerals rule under Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (the Conflict Minerals Rule). The rule requires public companies to disclose whether the
May 28, 2014	8-K	Other Events - FORM 8-K DATED MAY 28, 2014 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 28, 2014 ST. JUDE MEDICAL, INC. (Exact name of registrant as specified in its charter) Minnesota (State or other jurisdiction of incorporation) 1-12441 (Commission File Number) 41-
May 6, 2014	EX-12	ST. JUDE MEDICAL, INC. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (amounts in millions of dollars) EXHIBIT 12 ST. JUDE MEDICAL, INC. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (amounts in millions of dollars) Three Months Ended FISCAL YEAR March 29, 2014 2013 2012 2011 2010 2009 EARNINGS Earnings before income taxes $ 292 $ 784 $ 1,005 $ 1,019 $ 1,209 $ 1,057 Plus fixed charges: Interest expense (1) 21 81 73 70 67 46 Rent interest factor (2) 3 12 15 15 12 11 TOTAL FIXED CHARGES 24 93 88
May 6, 2014	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 29, 2014 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . Commission File Number: 1-12441 ST
May 6, 2014	EX-10.1	ST. JUDE MEDICAL, INC. MANAGEMENT INCENTIVE COMPENSATION PLAN (AS ADOPTED ON DECEMBER 9, 2013) Exhibit 10.1 ST. JUDE MEDICAL, INC. MANAGEMENT INCENTIVE COMPENSATION PLAN (AS ADOPTED ON DECEMBER 9, 2013) TABLE OF CONTENTS Section 1. Purpose 1 Section 2. Definitions 1 Section 3. Eligibility 1 Section 4. Administration 2 (a) Timing of Designations 2 (b) Adjustments 2 (c) Certifications 2 Section 5. Financial Performance Goals 2 Section 6. Payment of Incentive Compensation; Nonassignability 3 S
May 6, 2014	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits - FORM 8-K DATED MAY 1, 2014 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: May 1, 2014 (Date of earliest event reported) st. jude medical, inc. (Exact name of registrant as specified in its charter) Commission File Number: 1-12441 Minnesota 41-1276891 (State or other jurisdiction of incorpor
May 2, 2014	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: May 1, 2014 (Date of earliest event reported) st. jude medical, inc. (Exact name of registrant as specified in its charter) Commission File Number: 1-12441 Minnesota 41-1276891 (State or other jurisdiction of incorpor
April 16, 2014	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K DATED APRIL 16, 2014 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 16, 2014 ST. JUDE MEDICAL, INC. (Exact name of registrant as specified in its charter) Minnesota 1-12441 41-1276891 (State or other jurisdiction (Commission (IRS Employer of inco
April 16, 2014	EX-99.1	Condensed Consolidated Statements of Earnings (in millions) (Unaudited) Exhibit 99.1 St. Jude Medical, Inc. Global Headquarters One St. Jude Medical Drive St. Paul, MN 55117-9913 USA Tel 651 756 2000 sjm.com News Release MEDIA CONTACT: INVESTOR CONTACT: Amy Jo Meyer J.C. Weigelt [email protected] [email protected] Tel 651 756 3029 Tel 651 756 4347 St. Jude Medical Reports Third Quarter 2014 Results ST. PAUL, Minn. – April 16, 2014 – St. Jude Medical, Inc. (NYSE: STJ) toda
March 21, 2014	DEF 14A	- DEFINITIVE PROXY STATEMENT DEF 14A 1 stjude140861def14a.htm DEFINITIVE PROXY STATEMENT Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidentia
February 28, 2014	PRE 14A	- PRELIMINARY PROXY STATEMENT PRE 14A 1 stjude140525pre14a.htm PRELIMINARY PROXY STATEMENT Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: x Preliminary Proxy Statement o Confidenti
February 26, 2014	EX-21	ST. JUDE MEDICAL, INC. SUBSIDIARIES OF THE REGISTRANT as of December 28, 2013 EX-21 7 exhibit2112282013.htm SUBSIDIARIES OF THE REGISTRANT EXHIBIT 21 ST. JUDE MEDICAL, INC. SUBSIDIARIES OF THE REGISTRANT as of December 28, 2013 St. Jude Medical, Inc. Wholly Owned Subsidiaries: • Pacesetter, Inc. - Sylmar, California; Scottsdale, Arizona; and Maven, South Carolina (Delaware corporation) (dba St. Jude Medical Cardiac Rhythm Management Division) • St. Jude Medical S.C., Inc. -
February 26, 2014	EX-10.39	MULTI-YEAR CREDIT AGREEMENT Dated as of May 31, 2013 ST. JUDE MEDICAL, INC., as the Borrower, BANK OF AMERICA, N.A., as Administrative Agent, L/C Issuer and Lender, THE BANK OF TOKYO-MITSUBISHI UFJ, LTD. WELLS FARGO BANK, N. A. , as Co-Syndication Ag EXHIBIT 10.39 Published CUSIP Number: 85230DAN4 MULTI-YEAR $1,500,000,000 CREDIT AGREEMENT Dated as of May 31, 2013 among ST. JUDE MEDICAL, INC., as the Borrower, BANK OF AMERICA, N.A., as Administrative Agent, L/C Issuer and Lender, THE BANK OF TOKYO-MITSUBISHI UFJ, LTD. and WELLS FARGO BANK, N. A., as Co-Syndication Agents U.S. BANK NATIONAL ASSOCIATION, MIZUHO CORPORATE BANK, LTD., TD BANK, N.A
February 26, 2014	EX-10.6	SECOND AMENDMENT TO THE ST. JUDE MEDICAL, INC. MANAGEMENT SAVINGS PLAN Exhibit 10.6 12.28.2013 EXHIBIT 10.6 SECOND AMENDMENT TO THE ST. JUDE MEDICAL, INC. MANAGEMENT SAVINGS PLAN THIS INSTRUMENT, amending the St. Jude Medical, Inc. Management Savings Plan as restated effective January 1, 2008, is adopted by St. Jude Medical, Inc., a Minnesota corporation, (the ?Employer?), and shall be effective as of June 1, 2012. RECITALS WHEREAS, the Employer has heretofore establ
February 26, 2014	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 28, 2013 Commission File Number: 1-12441 ST. J 10-K 1 stj20131228201310-k.htm 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 28, 2013 Commission File Number: 1-12441 ST. JUDE MEDICAL, INC. (Exact name of registrant as specified in its charter) Minnesota 41-1276891 (State or other juri
February 26, 2014	EX-13	2013 vs. 2012 % Change Table of Contents EXHIBIT 13 Management's Discussion and Analysis of Financial Condition and Results of Operations OVERVIEW Our business is focused on the development, manufacture and distribution of cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas and implantable neurostimulation medical devices for the management of chronic pain.
February 26, 2014	EX-24	POWER OF ATTORNEY EXHIBIT 24 POWER OF ATTORNEY KNOW ALL BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Daniel J.
February 26, 2014	EX-10.40	TERM LOAN AGREEMENT Dated as of June 26, 2013 ST. JUDE MEDICAL, INC., as the Borrower, BANK OF AMERICA, N.A., as the Lender EXHIBIT 10.40 TERM LOAN AGREEMENT Dated as of June 26, 2013 between ST. JUDE MEDICAL, INC., as the Borrower, and BANK OF AMERICA, N.A., as the Lender 469696388 TABLE OF CONTENTS Section Page ARTICLE I. DEFINITIONS AND ACCOUNTING TERMS 1 1.01 Defined Terms 1 1.02 Other Interpretive Provisions 16 1.03 Accounting Terms 17 1.04 Rounding 17 1.05 References to Agreements and Laws 17 1.06 Times of Day 18
February 26, 2014	EX-12	ST. JUDE MEDICAL, INC. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (amounts in millions of dollars) EXHIBIT 12 ST. JUDE MEDICAL, INC. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (amounts in millions of dollars) FISCAL YEAR 2013 2012 2011 2010 2009 EARNINGS Earnings before noncontrolling interest and income taxes $ 784 $ 1,005 $ 1,019 $ 1,208 $ 1,057 Plus fixed charges: Interest expense (1) 81 73 70 67 46 Rent interest factor (2) 12 15 15 12 11 TOTAL FIXED CHARGES 93 88 85 79 57 EARNINGS BE
February 14, 2014	SC 13G/A	STJ / St. Jude Medical, Inc. / MASSACHUSETTS FINANCIAL SERVICES CO /MA/ - ST. JUDE MEDICAL, INC. Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2 (AMENDMENT NO. 4)* St. Jude Medical, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 790849103 (CUSIP Number) 12/31/2013 (Date of Event Which Requires Filing of this State
February 14, 2014	SC 13G/A	STJ / St. Jude Medical, Inc. / Wellington Management Group LLP - DISCLOSURE DOCUMENT Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* St. Jude Medical, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 790849103 (CUSIP Number) December 31, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this
January 29, 2014	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - FORM 8-K DATED JANUARY 27, 2014 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 27, 2014 ST. JUDE MEDICAL, INC. (Exact name of registrant as specified in its charter) Minnesota 1-12441 41-1276891 (State or other jurisdiction of incorporation) (Commission F
January 22, 2014	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K DATED JANUARY 22, 2014 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 22, 2014 ST. JUDE MEDICAL, INC. (Exact name of registrant as specified in its charter) Minnesota 1-12441 41-1276891 (State or other jurisdiction (Commission (IRS Employer of in
January 22, 2014	EX-99	4Q13 Sales Exhibit 99.1 St. Jude Medical, Inc. Global Headquarters One St. Jude Medical Drive St. Paul, MN 55117-9913 USA Tel 651 756 2000 sjm.com News Release MEDIA CONTACT: INVESTOR CONTACT: Amy Jo Meyer J.C. Weigelt [email protected] [email protected] Tel 651 756 3029 Tel 651 756 4347 St. Jude Medical Reports Fourth Quarter and Full-Year 2013 Results ST. PAUL, Minn. – Jan. 22, 2014 – St. Jude Medical, Inc. (N
January 13, 2014	EX-99.1	4Q13 Sales Exhibit 99.1 St. Jude Medical, Inc. Global Headquarters One St. Jude Medical Drive St. Paul, MN 55117-9913 USA Tel 651 756 2000 sjm.com News Release MEDIA CONTACT: INVESTOR CONTACT: Amy Jo Meyer J.C. Weigelt [email protected] [email protected] Tel 651 756 3029 Tel 651 756 4347 St. Jude Medical Announces Preliminary Fourth Quarter Financial Results ST. PAUL, Minn. – Jan. 13, 2014 – St. Jude Medical, In
January 13, 2014	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K DATED JANUARY 13, 2014 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 13, 2014 ST. JUDE MEDICAL, INC. (Exact name of registrant as specified in its charter) Minnesota 1-12441 41-1276891 (State or other jurisdiction (Commission (IRS Employer of in
December 9, 2013	EX-99.1	Revenue (by product category): Exhibit 99.1 Revenue (by product category): Fourth Quarter 2013 Full Year 2013 Cardiac Rhythm Management $655 million - $685 million $2.733 billion – $2.763 billion Atrial Fibrillation $235 million - $255 million $940 million – $960 million Cardiovascular $320 million - $340 million $1.305 billion – $1.325 billion Neuromodulation $105 million - $115 million $416 million – $426 million Earnings: Th
December 9, 2013	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Costs Associated with Exit or Disposal Activities 8-K 1 stjude1350748k.htm FORM 8-K DATED DECEMBER 5, 2013 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 5, 2013. ST. JUDE MEDICAL, INC. (Exact name of registrant as specified in its charter) Minnesota 1-12441 41-1276891 (S
November 6, 2013	EX-12	ST. JUDE MEDICAL, INC. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (amounts in millions of dollars) EXHIBIT 12 ST. JUDE MEDICAL, INC. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (amounts in millions of dollars) Nine Months Ended FISCAL YEAR September 28, 2013 2012 2011 2010 2009 2008 EARNINGS Earnings before income taxes $ 655 $ 1,005 $ 1,019 $ 1,209 $ 1,057 $ 581 Plus fixed charges: Interest expense (1) 60 73 70 67 46 73 Rent interest factor (2) 11 15 15 12 11 9 TOTAL FIXED CHARGES 71 88
November 6, 2013	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 28, 2013 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . Commission File Number: 1-1244
October 16, 2013	EX-99.1	3Q13 Sales Exhibit 99.1 St. Jude Medical, Inc. Global Headquarters One St. Jude Medical Drive St. Paul, MN 55117-9913 USA Tel 651 756 2000 sjm.com News Release MEDIA CONTACT: INVESTOR CONTACT: Amy Jo Meyer J.C. Weigelt [email protected] [email protected] Tel 651 756 3029 Tel 651 756 4347 St. Jude Medical Reports Third Quarter 2013 Results ST. PAUL, Minn. – Oct. 16, 2013 – St. Jude Medical, Inc. (NYSE: STJ) today
October 16, 2013	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 stjude1343038-k.htm FORM 8-K DATED OCTOBER 16, 2013 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 16, 2013 ST. JUDE MEDICAL, INC. (Exact name of registrant as specified in its charter) Minnesota 1-12441 41-1276891 (S
August 7, 2013	EX-10.2	ST. JUDE MEDICAL, INC. 2007 EMPLOYEE STOCK PURCHASE PLAN As Amended Effective August 1, 2013 EXHIBIT 10.2 ST. JUDE MEDICAL, INC. 2007 EMPLOYEE STOCK PURCHASE PLAN As Amended Effective August 1, 2013 4824-0811-7011 TABLE OF CONTENTS Page SECTION 1. INTRODUCTION 1 SECTION 2. DEFINITIONS 1 SECTION 3. ELIGIBILITY 3 SECTION 4. CONTRIBUTION PERIODS 3 SECTION 5. PARTICIPATION 3 SECTION 6. METHOD OF PAYMENT OF CONTRIBUTIONS 4 SECTION 7. GRANT OF OPTION 5 SECTION 8. EXERCISE OF OPTION; REFUND 5 SE
August 7, 2013	EX-12	ST. JUDE MEDICAL, INC. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (amounts in millions of dollars) EXHIBIT 12 ST. JUDE MEDICAL, INC. COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES (amounts in millions of dollars) Six Months Ended FISCAL YEAR June 29, 2013 2012 2011 2010 2009 2008 EARNINGS Earnings before income taxes $ 359 $ 1,005 $ 1,019 $ 1,209 $ 1,057 $ 581 Plus fixed charges: Interest expense (1) 39 73 70 67 46 73 Rent interest factor (2) 8 15 15 12 11 9 TOTAL FIXED CHARGES 47 88 85 79 5
August 7, 2013	8-K/A	Other Events - FORM 8-K/A TO FORM 8-K FILED OCTOBER 24, 2012 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 24, 2012 ST. JUDE MEDICAL, INC. (Exact name of registrant as specified in its charter) Minnesota 1-12441 41-1276891 (State or other jurisdiction of incorporation) (Commission
August 7, 2013	EX-99.1	EX-99.1

STJ / St. Jude Medical, Inc. - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

Mga Batayang Estadistika

SEC Filings

SEC Filings (Chronological Order)